Capabilities of Polypeptide Therapy in Treatment and Rehabilitation of Patients with Various Nosologies
Duration: 18 acad. hrs
Form of study: Distance learning (part-time, without interruption from work) using distance educational technologies
Issued document: Advanced Training Certificate
Price: 6,500 RUB
Program Objectives
To provide medical professionals, physician-researchers, and clinicians across disciplines (Internal Medicine, General Practice, Oncology, Gastroenterology, Hepatology, Clinical Pharmacology, Urology, Gynecology, Neurology) with evidence-based insights into the therapeutic role of polypeptide therapy in comprehensive patient rehabilitation, incorporating international clinical experience, post-COVID-19 recovery protocols, and applications in hepatology, gastroenterology, and comorbid conditions.
Competencies Enhanced Upon Program Completion
Upon completing this program, the student enhances professional competencies in applying modern polypeptide preparations based on recent scientific paradigms, managing patients with multiple chronic conditions, implementing polypeptide therapy in non-alcoholic fatty liver disease (NAFLD) with fibrosis, and optimizing clinical recovery across organ systems.
Knowledge Acquired During Training
- Pharmacodynamics, pharmacokinetics, and cellular signaling pathways of bioactive polypeptides;
- Clinical evidence supporting polypeptide therapy in hepatic fibrogenesis, metabolic dysfunction, and post-viral rehabilitation;
- Combination regimens with standard pharmacological therapies in chronic polymorbid patients.
Upon Completion, the Graduate Shall Be Able To
- Determine clinical indications and contraindications for polypeptide therapy in diverse clinical specialties;
- Formulate individualized treatment protocols and dosing schedules;
- Monitor laboratory markers of organ function and therapeutic efficacy during treatment.
Curriculum Outline
- Fundamental biological mechanisms of peptide bioregulation
- Polypeptide therapy in gastroenterology and hepatology: clinical trials and guidelines
- Peptide bioregulation in neurorehabilitation, immunology, and post-viral recovery
- Multimorbid patient management strategies
- Final assessment
Form of Final Assessment
Final assessment is conducted as a multiple-choice test consisting of 15 questions.
To successfully pass the assessment, at least 11 correct answers (out of 15) are required.
